Document Detail


Tocolytic treatment for the management of preterm labor: a review of the evidence.
MedLine Citation:
PMID:  12825006     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: Preterm labor is often a prelude to early births and the significant attendant burden of infant morbidity and mortality. Treatment consists of bedrest, hydration, pharmacologic interventions, and combinations of these. We systematically reviewed the effectiveness of tocolytics to stop uterine contractions (first-line therapy) or maintain quiescence (maintenance therapy). Our objective was to evaluate the evidence on the benefits and harms of five classes of tocolytic therapy for treating uterine contractions related to preterm labor--beta-mimetics, calcium channel blockers, magnesium, nonsteroidal anti-inflammatory agents, and ethanol. STUDY DESIGN: Reports of randomized controlled trials and other study designs in English, French, and German identified from searches of MEDLINE, EMBASE, specialized databases, bibliographies of review articles, unpublished literature, and discussions with investigators in the field were identified. Studies on women with preterm labor between 1966 and February 1999 that met our inclusion criteria were included. Through dual review, we abstracted the following information: study design and masking; definitions of preterm labor and successful tocolysis; patient inclusion/exclusion characteristics; patient demographic characteristics; drug and cointerventions; and numerous birth, maternal, and neonatal outcome measures. RESULTS: Of the 256 articles evaluated, we abstracted data from 60 first-line and 15 maintenance studies. Of these, 16 first-line and 8 maintenance studies met more stringent requirements for meta-analyses. Studies of first-line tocolysis (grade Fair) reveal a mixed outcome pattern with small improvement in pregnancy prolongation and birth at term relative to placebo. Data were insufficient to show directly a beneficial effect on neonatal morbidity or mortality. Ethanol was less beneficial than, and beta-mimetics were not superior to, other tocolytic options. Maintenance tocolytics (grade Poor) showed no improvements in birth or infant outcomes relative to placebo; these results were confirmed through meta-analysis. In contrast to other tocolytic treatments, maternal harms from beta-mimetics were rated High; all tocolytics were rated as Low risk for short-term neonatal harms. CONCLUSIONS: Management of uterine contractions with first-line tocolytic therapy can prolong gestation. Among the tocolytics, however, beta-mimetics appear not to be better than other drugs and pose significant potential harms for mothers; ethanol remains an inappropriate therapy. Continued maintenance tocolytic therapy has little or no value.
Authors:
Nancy D Berkman; John M Thorp; Kathleen N Lohr; Timothy S Carey; Katherine E Hartmann; Norma I Gavin; Victor Hasselblad; Anjolie E Idicula
Related Documents :
17879826 - Minimizing the risks from elective induction of labor.
4076926 - Duration of the third stage of labor in a female yellow baboon from mikumi national par...
16580286 - Tocolysis in women with preterm labor between 32 0/7 and 34 6/7 weeks of gestation: a r...
17122236 - Combined spinal epidural does not cause a higher sensory block than single shot spinal ...
3932776 - A breeding colony of cotton-top tamarins (saguinus oedipus).
19519846 - Molecular characterization of methicillin-resistant staphylococcus aureus from a fatal ...
Publication Detail:
Type:  Journal Article; Research Support, U.S. Gov't, P.H.S.; Review    
Journal Detail:
Title:  American journal of obstetrics and gynecology     Volume:  188     ISSN:  0002-9378     ISO Abbreviation:  Am. J. Obstet. Gynecol.     Publication Date:  2003 Jun 
Date Detail:
Created Date:  2003-06-25     Completed Date:  2003-07-25     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  0370476     Medline TA:  Am J Obstet Gynecol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1648-59     Citation Subset:  AIM; IM    
Affiliation:
Research Triangle Institute, Research Triangle Park, NC, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adrenergic beta-Agonists / adverse effects,  therapeutic use
Anti-Inflammatory Agents, Non-Steroidal / adverse effects,  therapeutic use
Bed Rest
Calcium Channel Blockers / adverse effects,  therapeutic use
Combined Modality Therapy
Ethanol / adverse effects,  therapeutic use
Female
Fluid Therapy
Humans
Magnesium Compounds / adverse effects,  therapeutic use
Obstetric Labor, Premature / drug therapy*
Pregnancy
Randomized Controlled Trials as Topic
Tocolytic Agents / adverse effects,  therapeutic use*
Grant Support
ID/Acronym/Agency:
290-97-0011//PHS HHS
Chemical
Reg. No./Substance:
0/Adrenergic beta-Agonists; 0/Anti-Inflammatory Agents, Non-Steroidal; 0/Calcium Channel Blockers; 0/Magnesium Compounds; 0/Tocolytic Agents; 64-17-5/Ethanol

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Evaluation of postoperative fever: usefulness and cost-effectiveness of routine workup.
Next Document:  Proceedings of the National Institute of Diabetes and Digestive and Kidney Diseases International Sy...